KIR3DL2 is a coinhibitory receptor on Sézary syndrome malignant T cells that promotes resistance to activation-induced cell death.

Blood

Institut National de la Santé et de la Recherche Médicale U976, Onco-Dermatology, Immunology and Cutaneous Stem Cells, Paris, France University Paris Diderot, Sorbonne Paris Cité, Paris, France.

Published: November 2014

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-09-598995DOI Listing

Publication Analysis

Top Keywords

kir3dl2 coinhibitory
4
coinhibitory receptor
4
receptor sézary
4
sézary syndrome
4
syndrome malignant
4
malignant cells
4
cells promotes
4
promotes resistance
4
resistance activation-induced
4
activation-induced cell
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!